Stav Tori CEO

Coming soon.

Therapeutic: In progress

Daniel Gelman CEO

Aufero Medical (London, Ontario, Canada) is transforming cardiac ablation with TruContact, a robotic tool enhancing catheter stability during ablation therapy for atrial fibrillation and heart rhythm disorders. Unstable catheters, an issue in half of procedures, reduce success rates. TruContact uses robotics and machine learning to ensure catheter stability, delivering high-quality ablations and empowering physicians of all skill levels. Partnered with leading EP market players, Aufero has raised over $1M, generated robust preclinical data, and secured strategic partnerships for global market expansion.

Therapeutic: Cardiovascular & Electrophysiology

Randy Pritchard CEO

Coming soon.

Therapeutic: In progress

Pim van Wesel CEO

CaverSTIM (Lausanne, Switzerland) is a novel implantable device able to restore natural penile erection by neuromodulation.

Therapeutic: Neuromodulation-Neurostimulation; Urology, Sexual Function

David Constantine Co-Founder & CEO

Coming soon.

Therapeutic category: In progress

Dom Messerli President & CEO

Based in Providence, Rhode Island, Lenoss Medical is a medical device company dedicated to the design, development and commercialization of a novel biological implant and associated delivery instrumentation for the treatment of painful vertebral compression fractures. Lenoss Medical developed the only fully biological solution for treating VCFs. The OsteoPearl Biological Augmentation is a minimally invasive spinal implant designed to stabilize the spinal fracture and create an environment for restoration and healing. Immediate stability is created by the structural matrix, introducing both osteoinductive and osteoconductive properties. Placing Natural bone where More bone is needed most.

Therapeutic: Pain management; Orthopedics-Spine

Lloyd Diamond CEO

Coming soon.

Therapeutic: In progress

Ze'ev Dvashi CEO

ClearPlasma (Nazareth, Israel) is a groundbreaking blood filtration device that removes plasminogen from plasma prior to transfusion—offering a novel, clinically validated solution to improve clot stability, reduce bleeding, and save lives in trauma, surgery, and critical care settings.

Therapeutic: Emergency care to treat massive blood loss

Allan Böhm Chief Executive & Medical Officer

Seerlinq (Slovakia, Bratislava) is the world’s first certified medical device enabling non-invasive, home-based monitoring of cardiac filling pressure—an essential parameter in managing heart failure. By detecting deterioration early, Seerlinq’s telemonitoring solution reduces heart failure hospitalizations by over 75%, addressing a global burden of more than 10 million admissions and $100 billion in annual healthcare costs.

Therapeutic: Remote Patient Monitoring; Heart Failure Diagnostics, Telemonitoring, Precision Medicine

Thomas Arnold CEO

ViCentra (The Netherlands - Utrecht) is transforming diabetes care with Kaleido, the smallest and lightest insulin patch pump system in its class. It’s a next-generation insulin pump system engineered for today’s users and tomorrow’s healthcare models. Kaleido delivers premium, flexible, and human-first diabetes technology designed to outperform outdated, one-size-fits-all solutions with a seamless blend of performance, lifestyle integration, and user satisfaction.

Therapeutic: Diabetes management; Insulin delivery system; Medical devices – Continuous Subcutaneous Insulin Infusion (CSII) systems